Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 284.67M P/E 34.37 EPS this Y 50.70% Ern Qtrly Grth -
Income -69.24M Forward P/E -9.33 EPS next Y -14.60% 50D Avg Chg -11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 6.34 EPS next 5Y - 52W High Chg -83.00%
Recommedations 1.20 Quick Ratio 4.92 Shares Outstanding 43.59M 52W Low Chg 34.00%
Insider Own 59.43% ROA -73.79% Shares Float 7.81M Beta 0.54
Inst Own 45.92% ROE -173.05% Shares Shorted/Prior 628.33K/358.24K Price 6.53
Gross Margin - Profit Margin - Avg. Volume 767,314 Target Price 16.40
Oper. Margin - Earnings Date - Volume 92,988 Change -5.09%
About Zura Bio Limited

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Zura Bio Limited News
04/18/24 Zura Bio Announces Oversubscribed $112.5 Million Private Placement
04/08/24 Zura Bio Announces Robert Lisicki as CEO and Director
04/02/24 Insider Buyers At Zura Bio Recover Some Losses, But Still Down US$165k
03/28/24 Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
03/04/24 Zura Bio Announces Participation at March Conferences
02/02/24 Zura Bio Announces Participation at February Investor Conferences
01/08/24 Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
01/03/24 Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
12/04/23 Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok
11/14/23 Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
11/13/23 Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights
09/12/23 Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute
09/07/23 We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely
09/05/23 Oppenheimer Says These 2 Stocks Could Double Your Money — Here’s Why They Could Jump
08/25/23 Netflix upgraded, Olaplex downgraded: Wall Street's top analyst calls
08/14/23 Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights
06/23/23 Zura Bio to Join the Russell 2000® and Russell 3000® Indexes
06/06/23 Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist
06/01/23 ‘Load Up,’ Says Raymond James About These 2 ‘Strong Buy’ Stocks
04/27/23 Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases
ZURA Chatroom

User Image CrossoverNinja Posted - 1 day ago

$ZURA yuuuppp!!!

User Image DonCorleone77 Posted - 1 day ago

Ron, are you following $ZURA? They announced an oversubscribed private placement this morning:

User Image shelby1 Posted - 1 day ago

$ZURA any PDFUAs coming up on this. I forgot that I bought it over a year ago and haven't look at any DD lately?

User Image mcrotary Posted - 1 day ago

$ZURA this can surprise

User Image Stocktwit247 Posted - 1 day ago

$ZURA where are the buyers?

User Image DonCorleone77 Posted - 1 day ago

$ZURA I don't know about this one. Shorts may want to cover. Oversubscribed and funded through 2027.

User Image _www_larval_com_ Posted - 1 day ago

$BNTC 7%[29%] $ZURA 5%[13%] $IZM -5%[-18%] $INDO 3%[3%] $PLCE 3%[9%] most notable movement within the first minutes of trading.

User Image DonCorleone77 Posted - 1 day ago

$ZURA Zura Bio to sell 20.1M shares at $3.11 in oversubscribed private placement Zura Bio announced that it has entered into subscription agreements for a private placement that is expected to result in gross proceeds of approximately $112.5M, before deducting placement agent fees and offering expenses. The private placement is led by Access Biotechnology and a life sciences-focused institutional investor, and includes participation from other new and existing investors, including RA Capital Management, Deep Track Capital, Great Point Partners, Suvretta Capital, funds managed by Allostery Investments LP, Armistice Capital, and other large investment management firms. Zura Bio has agreed to sell an aggregate of approximately 20.1M Class A ordinary shares at a purchase price of $3.108 per share, and, in lieu of Class A ordinary shares to certain investors, pre-funded warrants to purchase up to an aggregate of 16.1M Class A ordinary shares at a purchase price of $3.107 per pre-funded warrant. Each pre-funded warrant will have an exercise price of $0.001 per ordinary share and will be immediately exercisable and remain exercisable until exercised in full. The private placement is being conducted in accordance with applicable Nasdaq rules and was priced to satisfy the "Minimum Price" requirement. The private placement is expected to close on April 22, subject to satisfaction of customary closing conditions. Anticipated proceeds from the private placement are expected to support the accelerated development of tibulizumab, including the planned Phase 2 clinical trial in systemic sclerosis, the initiation of a Phase 2 trial evaluating tibulizumab for the treatment of hidradenitis suppurativa, and general corporate purposes. The combination of anticipated net proceeds with existing cash and cash equivalents is expected to support operations through 2027.

User Image Stocktwit247 Posted - 1 day ago

$ZURA Huge news with massive names.. will run hard

User Image harristradez Posted - 1 day ago

$ZURA 112 million is a lot!!

User Image harristradez Posted - 1 day ago

$ZURA news!! WW

User Image Stock_Titan Posted - 1 day ago

$ZURA Zura Bio Announces Oversubscribed $112.5 Million Private Placement https://www.stocktitan.net/news/ZURA/zura-bio-announces-oversubscribed-112-5-million-private-5yfuut7oi050.html

User Image Fullratio Posted - 4 days ago

$ZURA debt is 100% smaller than its equity: https://fullratio.com/stocks/nasdaq-zura/zura-bio

User Image BearishAlgo Posted - 1 week ago

$ZURA

User Image deniz100 Posted - 1 week ago

$ZURA Massive breakout

User Image briefingcom Posted - 1 week ago

$ZURA: Zura Bio Limited announces Robert Lisicki as CEO and Director https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240408060431ZURA&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Stock_Titan Posted - 1 week ago

$ZURA Zura Bio Announces Robert Lisicki as CEO and Director https://www.stocktitan.net/news/ZURA/zura-bio-announces-robert-lisicki-as-ceo-and-eytsngkt6b75.html

User Image Orlandotrader Posted - 03/28/24

$ZURA Said it once say it again SCAM!!! Why did this company go public last Summer just to Rob Shareholders. Haven’t even started a Clinical trial. CEO out. Oh yeah I answered my own question “ To Rob Shareholders “

User Image TheJunksCalls Posted - 03/26/24

$DHAI <~~ 💥🔫 Easy Money. 39% swing play ✅ Still looking for a massive run here back over $2.00+ $MNY $ZURA $FRGE

User Image 1WELLDONE Posted - 03/25/24

$ZURA fool me once Out for even Garbage. Waste of a trade.

User Image BearSqueeZZzzz Posted - 03/25/24

$ZURA Analysts Buy Rating 82%. Price is bouncing off the Declining Wedge Support Line. Order Flow is positive. Moderate accumulation off lows.

User Image PumpmeDumpme Posted - 03/25/24

$ZURA haha, fake bids at $ 2.42 watch for the rug pull : )

User Image _StockTrader Posted - 03/25/24

Real-Time Stock Data $ZURA Price: 3.36 Volume: 2866415 Market Cap: 120748552 PE Ratio: -2.9808512 Powered by: AITX

User Image WeAreNotTheSame Posted - 03/25/24

$ZURA This is running on no news and up from the low of two dollars. I dont see a good entry here but I will keep an eye on it.

User Image BenKaitz Posted - 03/25/24

$ZURA took a losing play and made it into a winning play by sticking to my own DD.

User Image UsandThem7 Posted - 03/25/24

$ZURA moving to $CYTO

User Image fastmoneytraderz Posted - 03/25/24

shorted $ZURA 2.93 covered 2.65

User Image VrtcIl Posted - 03/25/24

How much more potential do you see on $ZURA? 4? 5? 7? Look for key indicators such as trend strength, support and resistance levels, and potential breakout or reversal patterns. Price: 3.07 Float: 20.6M Short Float: 1.9 % 💰 Dollar Volume: 792.6K ℹ️ USA | Biotechnology

User Image _www_larval_com_ Posted - 03/25/24

$ZURA just jumped 12% higher to 32% (~220Kv) a few minutes ago, follow for more volatility.

User Image LeroyRunner Posted - 03/25/24

$ZURA got in premarket. Good start

Analyst Ratings
Oppenheimer Outperform Apr 1, 24
Ladenburg Thalmann Buy Oct 10, 23
Oppenheimer Outperform Aug 25, 23
Raymond James Strong Buy Aug 15, 23
Guggenheim Buy Jun 22, 23
Chardan Capital Buy Jun 14, 23
Raymond James Strong Buy May 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Thiara Parvinder Director Director Dec 12 Sell 4.00 2,000,000 8,000,000 4,801,633 12/14/23
Munshi Amit Director Director Jun 05 Buy 4.25 117,647 500,000 617,640 06/05/23